BVS

BIOVENTUS INC.

BVS · CIK 1665988 · Annual (10-K) · Last 4 years

Financial Trends

Revenue$573M
20212024
Net Income−$34M
20212024
Operating CF$39M
20212024
Free Cash Flow$38M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.6B$0.5B$0.5B$0.4B
Cost of Revenue$0.2B$0.2B$0.2B$0.1B
Gross Profit$0.4B$0.3B$0.3B$0.3B
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.3B$0.3B$0.3B$0.3B
Operating Income$-0.0B$-0.1B$-0.3B$0.0B
Net Income$-0.0B$-0.2B$-0.2B$-0.0B
EPS (Basic)$-0.52$-2.49$-2.59$-0.15
EPS (Diluted)$-0.52$-2.49$-2.59$-0.15

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.7B$0.8B$1.4B$1.2B
Current Assets$0.3B$0.3B$0.3B$0.3B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.5B$0.6B$1.0B$0.7B
Current Liabilities$0.2B$0.2B$0.3B$0.2B
Stockholders' Equity$0.1B$0.2B$0.3B$0.5B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$0.0B$0.0B$-0.0B$0.0B
Investing Cash Flow$0.0B$0.0B$-0.1B$-0.3B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.1B$-0.0B$0.1B$0.3B
← Companies